HLN.L - LONDON STOCK EXCHANGE
Industry: Pharmaceuticals
Market Cap: 34.4 B
IPO Date: Jul 18, 2022
Country: GB
Currency: GBP
Shares Outstanding: 9.0 B
6/24/2025
While pharmaceutical drug pricing is making headlines amid President Trump's proposal to benchmark U.S. retail drug costs to international standards, less attention is being paid to attractive, albeit less-glamorous investment areas in the global health ecosystem, according to Stewart Investors, a long-only active global equity specialist.
Source: Yahoo
6/24/2025
Haleon (LSE: HLN) (NYSE: HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.
Source: Yahoo
6/12/2025
The fund underperformed the benchmark during the last quarter.
Source: SeekingAlpha
5/8/2025
Most readers would already be aware that Haleon's (LON:HLN) stock increased significantly by 13% over the past month...
Source: Yahoo
5/2/2025
Haleon plc (NYSE:HLN) Q1 2025 Results Conference Call April 30, 2025 3:30 PM ETCompany ParticipantsJo Russell - Head-Investor RelationsDawn Allen - Chief...
Source: SeekingAlpha
5/1/2025
LONDON & SAN FRANCISCO, May 01, 2025--Brightseed and Haleon and Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation
Source: Yahoo
4/29/2025
Franklin Mutual Beacon Fund (Class Z) outperformed its benchmark, the MSCI World Value Index, for the quarter ended March 31, 2025. Read more here.
Source: SeekingAlpha
4/25/2025
Earnings preview of key companies reporting next week and what to look out for.
Source: Yahoo
4/13/2025
During the first quarter, the ClearBridge International Growth ACWI Ex-US Strategy outperformed its MSCI ACWI Ex-U.S. Index benchmark. Read more here.
Source: SeekingAlpha
4/11/2025
Harding Loevner International Equity composite gained 5.2% (gross) for Q1 2025, nearly matching the 5.4% gain of the MSCI ACWI ex US Index. Click here to read the full commentary.
Source: SeekingAlpha